Evidence-based medicine for pediatric thrombosis is in its infancy. As recently as 10 years
ago, antithrombotic therapy for infants and children was largely based on individual empiric …

Background—Infants and young children with certain types of heart disease are at increased
risk for thromboses. Clopidogrel 75 mg/d is used in adults to prevent thrombotic events. The …

Cardiovascular disease (CVD), principally heart disease and stroke, is the leading cause of
death for both males and females in developed countries. Aspirin is the most widely used …

Venous thromboembolism (VTE) is rare in healthy children, but is an increasing problem in
children with underlying medical conditions. Pediatric VTE encompasses a highly …

OBJECTIVE: To identify predictors of antithrombotic treatment in neonates with cerebral
sinovenous thrombosis (CSVT) in a large multinational study. STUDY DESIGN: Neonates …

Abstract Extracorporeal Membrane Oxygenation (ECMO) is a form of Extracorporeal Life
Support (ECLS) which is used frequently in the paediatric and neonatal setting to support …

Use of central venous catheters has become standard in the treatment of many chronic
conditions during childhood and for the acute treatment of critically ill infants and children …

This update uses an evidence based approach to analyze and present the epidemiology of
neonatal thrombosis, etiologies, currently used techniques for diagnosis with their …

Unfractionated heparin is frequently used in tertiary pediatric centers for the prophylaxis and
treatment of thromboembolic disease. Recent evidence suggests that the clinical outcomes …

With improved pediatric survival from serious underlying illnesses, greater use of invasive
vascular procedures and devices, and a growing awareness that vascular events occur …